ContractClinical Study Site Agreement • February 28th, 2019
Clinical Study Site Agreement Smlouva s centrem klinické studie This Clinical Study Site Agreement (“Agreement”), entered into as of the last date of signature (“Date of Final Signature”) and effective as set out in Section 26 below, is entered into by and among: Tato Smlouva s centrem klinické studie (dále jen „smlouva“), uzavřená ke dni data posledního podpisu (dále jen „datum posledního podpisu“) a vstupující v platnost tak, jak je stanoveno v bodu 26 níže, se uzavírá mezi těmito stranami: Fakultní nemocnice Ostrava, located at 17. listopadu 1790/5, Ostrava – Poruba, 708 52, Czech Republic, IČ: 00843989, DIČ: CZ00843989, Establishment list of the Ministry of Health of 25 November 1990 File no. OP- 054-25.11.90, in the affairs of this contract is entitled to act and sign:, Deputy Director of Science and Research, (“Institution”) Fakultní nemocnice Ostrava, se sídlem na adrese 17. listopadu 1790/5, Ostrava – Poruba, 708 52, Česká republika, IČ: 00843989, DIČ: CZ00843989, Zřizovací lis
Clinical Study Site AgreementClinical Study Site Agreement • June 14th, 2017
This Clinical Study Site Agreement (the “Agreement”), effective as of the date of the last signature below, is entered into by and between:
TO CLINICAL STUDY SITE AGREEMENTClinical Study Site Agreement • January 16th, 2018
This Amendment #1 (the “Amendment”), effective at the date of the publication in contract register (the “Effective Date”), modifies and amends the Clinical Study Site Agreement for Protocol Number
ContractClinical Study Site Agreement • January 24th, 2017
Clinical Study Site Agreement This Clinical Study Site Agreement (the “Agreement”), entered into as of the date of the last signature below (“Date of Final Signature”) and effective as set out in Section 23 below, is entered into by and between: : Nemocnice Strakonice, a.s., located at Radomyšlská 336, 386 29, Strakonice, Czech Republic, Identification number: 260 95 181, registered in Commercial Companies registry by Regional Court in České Budějovice, inlet B 1465, represented by MUDr. Bc. Tomáš Fiala, MBA, Chairman of Board of Directors and Ing. Luboš Kvapil, Vice-Chairman of Board of Directors (“Institution”), Quintiles Czech Republic, s.r.o. located at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00, Identification number: 247 68 651, based upon a power attorney represented by ……………………………... (“CRO”), for the purpose of conducting the clinical study (the “Study”) described in the protocol entitled “A Randomized, Double-Blind, Proof-of-Concept, Phase 2 Study to Eva
ContractClinical Study Site Agreement • June 14th, 2017
AMENDMENT NO. 1TO CLINICAL STUDY SITE AGREEMENTPROTOCOL NUMBER MLN0002SC-3027 This Amendment No. 1 to Clinical Study Site Agreement (“Amendment”), effective as of the date of the last signature below, is entered into by and between: Nemocnice Tábor, a.s., located at kpt. Jaroše 2000, 390 03 Tábor, Czech Republic, Company ID no.: 26095203, Tax ID no.: CZ26095203,represented by Ing. Ivo Houška, MBA, Chairman of the Board of Directors, and MUDr. Jana Chocholová,Vice-Chairman of the Board of Directors (“Institution”), Quintiles Czech Republic, s.r.o. located at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00,Identification number: 247 68 651, registered in the Commercial Register of Městský soud v Praze, section C, insert 172751, represented by Alasdair MacDonald (“CRO”) for the purpose of amending the Clinical Study Site Agreement among Institution and CRO dated 20 July 2016 (the “Agreement”) relating to the conduct of the clinical research (the “Study”) described in the protocol en
ContractClinical Study Site Agreement • November 23rd, 2016
Clinical Study Site Agreement This Clinical Study Site Agreement (the “Agreement”), effective as of the date of the last signature below, is entered into by and between: Fakultní nemocnice Královské Vinohrady, located at Šrobárova 50, 100 34 Praha 10, Czech RepublicCompany ID: 000 64 173,Tax identification number: CZ00064173, represented by MUDr. Andrea Vrbovská, MBA, Director, reference symbol KH 30/2015, internal cost center no. 22046(“Institution”), Quintiles Czech Republic, s.r.o. located at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00,Identification number: 247 68 651, Tax ID: CZ24768651, (“CRO”), for the purpose of conducting the clinical study (the “Study”) described in the protocol entitled “A single arm open label study to assess mucosal healing in patients with moderately to severely active Crohn’s Disease treated with Vedolizumab”, Protocol No. MLN0002- 3028 (the “Protocol”) of which Takeda Development Centre Europe Ltd (“Sponsor”) is sponsor. With respect to the ri
ContractClinical Study Site Agreement • April 10th, 2019
Clinical Study Site Agreement Smlouva s centrem klinické studie This Clinical Study Site Agreement (“Agreement”), entered into as of the last date of signature (“Date of Final Signature”) and effective as set out in Section 25 below, is entered into by and among: Tato Smlouva s centrem klinické studie (dále jen „smlouva“), uzavřená ke dni data posledního podpisu (dále jen „datum posledního podpisu“) a vstupující v platnost tak, jak je stanoveno v bodu 25 níže, se uzavírá mezi těmito stranami: Fakultní nemocnice Brno, located at Jihlavská 20, Brno, 625 00, Czech Republic, registration No: 65269705, VAT No: CZ65269705,executive director: (“Institution”), Fakultní nemocnice Brno, se sídlem na adrese Jihlavská 20, Brno, 625 00, Česká republika, IČ: 65269705, DIČ: CZ65269705, jednající:- ředitel (dále jen„zdravotnické zařízení“), nar. nar. , bytem , bytem lékař Interní lékař Interní hematologické a onkologické kliniky Fakultní nemocnice Brno ("Investigator"), hemat
ContractClinical Study Site Agreement • July 15th, 2019
Clinical Study Site Agreement Smlouva s Místem provádění klinického hodnocení This Clinical Study Site Agreement (“Agreement”), entered into as of the last date of signature (“Date of Final Signature”) and effective as set out in Section 26 below, is entered into by and among: Tato Smlouva s Místem provádění klinického hodnocení (dále jen „Smlouva“) uzavřená k datu posledního podpisu („Datum posledního podpisu“), s účinností stanovenou v článku 26 níže, kterou mezi sebou uzavřeli: Všeobecná fakultní nemocnice v Praze, located at U Nemocnice 499/2, 128 08 Praha 2, Czech Republic, Identification number: 00064165, Tax identification number: CZ00064165, represented byunder a power of attorney(“Institution”), Všeobecná fakultní nemocnice v Praze, se sídlem U Nemocnice 499/2, 128 08 Praha 2, Česká republika, Identifikační číslo: 00064165, Daňové identifikační číslo: CZ00064165, zastoupená , na základě plné moci (dále jen„Zdravotnické zařízení“), , born onresiding at (“Investigator”),
